NYSEMKT: NNVC
Nanoviricides Inc Stock Ownership - Who owns Nanoviricides?

Insider buying vs selling

Have Nanoviricides Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when NNVC insiders and whales buy or sell their stock.

NNVC Shareholders

What type of owners hold Nanoviricides Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Theracour Pharma Inc207.32%33,321,000$48.32MInsider
Milton Boniuk92.26%14,827,438$21.50MInsider
Anil Diwan12.72%2,044,918$2.97MInsider
Eugene Seymour7.77%1,248,814$1.81MInsider
Vanguard Group Inc3.18%510,416$740.10kInstitution
Stephenson Fournier PLLC3.06%491,721$713.00kInsider
Meeta Vyas2.74%439,570$637.38kInsider
Blackrock Inc0.99%158,752$230.19kInstitution
Geode Capital Management LLC0.98%157,994$229.09kInstitution
Ubs Group Ag0.73%117,168$169.89kInstitution

1 of 3

NNVC vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
NNVC2.49%97.51%
LEXX11.75%4.18%Net BuyingNet Buying
QTTB30.40%69.60%Net BuyingNet Selling
PMN16.36%46.67%Net Buying
NRXS8.57%25.80%Net SellingNet Selling

Nanoviricides Stock Ownership FAQ

Who owns Nanoviricides?

Nanoviricides (NYSEMKT: NNVC) is owned by 8.31% institutional shareholders, 325.87% Nanoviricides insiders, and 0.00% retail investors. Theracour Pharma Inc is the largest individual Nanoviricides shareholder, owning 33.32M shares representing 207.32% of the company. Theracour Pharma Inc's Nanoviricides shares are currently valued at $48.32M.

If you're new to stock investing, here's how to buy Nanoviricides stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.